To verify if the lack of complement activation we observed was due to IgG4 disease induced hypocomplementemia, the levels of C3 and C4 proteins were quantified in the serum of the patient before each session of treatment (i.e., before treatment 1 and 6). The gene discussed is C4A; the disease is glycogen storage disease VI.